SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
ALXN
--
0.00%
--
Alexion (ALXN) Up 17.3% Since Last Earnings Report: Can It Continue?
Alexion (ALXN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 1d ago
The Nasdaq 100 just hit a new record. Here are Wall Street's favorite picks to lead it even higher
Take a look at the Nasdaq 100 stocks that Wall Street believes have room to run.
CNBC.com · 2d ago
Alexion to Present at the 41st Annual Global Goldman Sachs Healthcare Conference
Business Wire · 2d ago
Merger Arbs Are Confident Despite Whispers About Tiffany
marketwatch.com · 2d ago
AstraZeneca Ranked Most Inventive, Roche Most Innovative
GuruFocus.com · 4d ago
3 Top Stocks That Will Make You Richer in June (and Beyond)
MotleyFool.com · 4d ago
Alexion Pharmaceuticals (ALXN) Stock Sinks As Market Gains: What You Should Know
Zacks · 4d ago
Credit Suisse Maintains Outperform on Alexion Pharmaceuticals, Raises Price Target to $147
Credit Suisse maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and raises the price target from $142 to $147.
Benzinga · 5d ago
Betting on Boeing to Fly Out of the Storm Clouds
Barrons.com · 05/30 00:38
Alexion (ALXN) Catches Eye: Stock Jumps 7.8%
Zacks · 05/29 14:38
SVB Leerink Maintains Outperform on Alexion Pharmaceuticals, Raises Price Target to $159
SVB Leerink maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and raises the price target from $150 to $159.
Benzinga · 05/29 11:45
Why This Event Could Clear The Deck For An Alexion Takeover: Analyst
Investor's Business Daily · 05/28 21:13
Nasdaq Today: Why Alexion and Workday Stock Are Soaring
MotleyFool.com · 05/28 18:16
Dow Jones Today, Stocks Flatten As U.S., China Enter Cold War; Facebook Falls On White House Threat
Alexion Pharmaceuticals and Workday were early leaders Thursday, while Boeing hoisted the Dow Jones, as the U.S. and China entered a cold war.
Investor's Business Daily · 05/28 13:49
Alexion Stock Jumps on Signal That Fight Over Patent May End Soon
Amgen has challenged Alexion’s exclusive rights to its blockbuster drug Soliris, a move that has been a significant worry for Alexion investors. A judge wrote Wednesday that the parties have reached an agreement in principle.
Barrons.com · 05/28 13:27
ARNC, ALXN among premarket gainers
Seeking Alpha - Article · 05/28 13:20
Is Alexion Pharmaceuticals, Inc.'s (NASDAQ:ALXN) CEO Paid Enough Relative To Peers?
Simply Wall St. · 05/28 11:03
Hedge Funds Have Never Been This Bullish On Alexion Pharmaceuticals, Inc. (ALXN)
Insider Monkey · 05/27 18:05
Healthcare And Biotechnology Dashboard - Update
Seeking Alpha - Article · 05/26 23:03
Here's Why argenx Stock Is Soaring Today
MotleyFool.com · 05/26 04:00